Craig Malcolm,
Strategic Collaborations Manager,
Promega UK Ltd
After receiving his PhD in Neurochemistry from St Andrews University, Dr Malcolm spent seven years in the pharmaceutical industry as a Team Leader in Molecular Pharmacology (Vernalis), developing cell-based assays and supporting drug discovery screening projects. After several more years in product development at PerkinElmer, and various other commercially-focussed roles in several other UK-based Life Science companies (Scientifica, Roche Applied Science), he joined Promega UK and is currently Strategic Collaborations Manager with a focus on new and emerging technology platforms for drug discovery and biologics.
|
|
|
Add to Calendar ▼2016-02-09 14:15:002016-02-09 15:15:00Europe/LondonCell-Based Bioassays And Reagents For Therapeutic Antibody Discovery And CharacterisationAntibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com
